Compound heterozygous RPE65 mutations associated with an early onset autosomal recessive retinitis pigmentosa.

Evaluation of all previously described RPE65 mutations showed that the sequence variants identified in the present study located to rarely altered exons and likely effect a highly conserved region of the RPE65 protein. Gene augmentation therapies might be a promising treatment option for the patients described.